CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Office FUWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug3155 Zinc gluconate Wiki 1.00
drug2851 Telemedicine FU Wiki 1.00
drug29 25-OH cholecalciferol Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D054058 Acute Coronary Syndrome NIH 0.45
D013577 Syndrome NIH 0.10

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Telemedicine Follow-up for Post-Acute Coronary Syndrome Patients

The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients

NCT04485754 ACS - Acute Coronary Syndrome Other: Telemedicine FU Other: Office FU
MeSH:Acute Coronary Syndrome Syndrome

Primary Outcomes

Description: Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke

Measure: MACCE

Time: 1 year

Secondary Outcomes

Description: High Level of Medical Therapy Optimization is defined as a participant meeting all of the following goals: LDL < 1.4 mmol/L and on any statin, blood pressure < 140/90 mm/Hg (<135/85 mm/Hg for patients with diabetes mellitus), on aspirin or other antiplatelet or anticoagulant, and not smoking. High level of medical therapy optimization is missing if any of the individual goals are missing.

Measure: High level of MT optimization

Time: 1 year

Description: Blood pressure < 140 mm/Hg (<135/85 mm/Hg for for patients with diabetes mellitus)

Measure: PB < 140/90 mm/Hg (<135/85 mm/Hg for Diabetes)

Time: 1 year

Description: Low density lipoprotein< 1.4 mmol/L

Measure: LDL < 1.4 mmol/L

Time: 1 year

Description: Not smoking

Measure: Not smoking

Time: 1 year

Description: Decrease in overweight

Measure: Decrease in overweight

Time: 1 year

Description: Adherence to aspirin or other antiplatelet or anticoagulant

Measure: Aspirin or other antiplatelet or anticoagulant

Time: 1 year

Description: Adherence to prescribed at discharge medication

Measure: Adherence to prescribed medication

Time: 1 year

Description: Hospitalization for cardiac reasons

Measure: Hospitalization

Time: 1 year


No related HPO nodes (Using clinical trials)